Familial Adenomatous Polyposis (FAP) Known Mutation
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Predictive testing for familial adenomatous polyposis when a mutation has been identified in an affected family member
Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request
Documentation of the specific familial mutation must be provided with the specimen in order to perform this test.
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
DNA Sequencing or Dosage Analysis by Multiplex Ligation-Dependent Probe Amplification (MLPA) (Test is used for detecting the presence of a specific mutation previously identified in an affected family member.)
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
FAP Known Mutation
APC (Adenomatous Polyposis Coli)